EUACCIssue #11 · 20–27 Jul 2026
Humanoid became Europe's first humanoid robotics unicorn this week. Six days before Europe's biggest AI compliance deadline hits, the EU rewrote who it applies to.
🧠The Big Picture
The Compliance Rewrite
The EU's most consequential AI deadline — August 2, 2026, six days from now — no longer applies in its original form. The Digital Omnibus on AI, signed July 8 and awaiting publication in the Official Journal, defers high-risk AI obligations for Annex III applications from August 2, 2026 to December 2, 2027 — a 16-month extension. AI embedded in regulated products gets longer still: to August 2, 2028.
The coverage reads this as a retreat. That is the wrong frame. What the Omnibus traded in exchange for time is significant. The definition of high-risk has been narrowed: AI that merely assists users or optimises performance without creating health or safety risks is now explicitly excluded from Annex III obligations. The SME compliance threshold has been raised to companies with up to 750 employees and €150 million in annual revenue — capturing most growth-stage European startups — and that bracket now gets simplified guidance, reduced fines, regulatory sandbox access, and standardised documentation templates. GDPR-protected special-category data can now be used for AI bias testing and mitigation, removing a significant friction point for health and HR applications.
The structural read: a meaningful share of AI systems that founders had scoped as high-risk are now either out of scope entirely or face materially lighter obligations. European AI incumbents who had invested heavily in compliance infrastructure hold a narrowed advantage. For any startup that had been deferring product decisions waiting for regulatory clarity, the Omnibus delivers both: the definitions have sharpened, and the clock has reset. The coincidence with Humanoid's unicorn milestone this week — Europe's first pure-play humanoid robotics company at $1.35B — underlines the point. Physical AI systems that assist workers on factory floors are now explicitly positioned outside the high-risk definition. The compliance rewrite is not separate from the physical AI story.
📋Grant World
Eleven Weeks to the EIC
The short application window for EIC Accelerator is nine days away. Beyond that, a cluster of September deadlines makes the next six weeks the most consequential grant sprint of the year.
Deadlines in the next ~8 weeks:
⚠️ Women TechEU — 28 Jul (tomorrow) · €75K equity-free · Women-led deep-tech, EU/Associated countries, woman CEO or CTO holding ≥25% equity · Rolling weekly cutoffs continue through 2028; next window after tomorrow is 4 August
EIC Accelerator (short application) — 5 Aug 2026 · Monthly gateway to grants up to €2.5M + equity investment up to €17.5M · A 2–3 page submission; the on-ramp to the September full-proposal cycle
Eurostars 3 Call 11 — 10 Sep 2026 · €300K–€500K per partner · Cross-border R&D, SME-led, at least two partners from two Eurostars countries · Around 20% success rate — higher than most EIC instruments
EIC Accelerator (full proposal) — 2 Sep 2026 · The main EIC deadline of the year · Up to €2.5M grant + €17.5M equity · Approximately 5,700 short applications compete for roughly 300 full-proposal invitations per cohort
EIC Transition — 16 Sep 2026 · Up to €2.5M, no equity component · TRL 3–5 deep-tech bridge from laboratory proof of concept to validated prototype · The only Transition deadline in 2026
EIC Pathfinder (Challenges) — 28 Oct 2026 · €96M available · Long-horizon, high-risk research; single-applicant eligible for some challenge calls · Under-applied relative to Accelerator
EIC evaluators score regulatory risk explicitly. If your compliance narrative was written against pre-Omnibus definitions of high-risk AI, the September 2 deadline is your opportunity to update it.
💶Who Got Funded
Robots, Scanners, and Orbital Contracts
Neko Health — Stockholm, Sweden · $700M · Series C · Preventive health / Diagnostic imaging · Lightspeed Venture Partners (lead), O.G. Venture Partners (co-lead), General Catalyst, Atomico, Lakestar, Liberty City Ventures, Positive Sum, BDT & MSD
Founded by Spotify's Daniel Ek and Hjalmar Nilsonne, Neko's non-invasive full-body scans now value the company at $7B — a fourfold increase from its $1.7B Series B 18 months ago. The $700M funds US clinic openings in New York. Europe has its first billion-dollar preventive health company heading west.
Humanoid — London, UK · $152M · Series A · Humanoid robotics / Physical AI · Prime Movers Lab (lead), Schaeffler, Bosch, Fubon Financial, Aglaé Ventures
Valued at $1.35B — Europe's first pure-play humanoid robotics unicorn, two years after founding. Bosch will manufacture the robots at scale; Schaeffler has contracted deployment of thousands of units. The round is simultaneously equity and offtake commitment.
Arrakis — London & Paris, UK/France · $38M · Series A · Industrial AI / Agentic systems · Blossom Capital (lead), Accel, GFC; angels include Datadog CEO Olivier Pomel and OpenAI's Olivier Godement
Seven months old, emerging from stealth July 22. Builds an AI operating system for aerospace, energy, logistics, and manufacturing — sectors where AI deployment has lagged consumer markets by five to seven years. Blossom Capital backed both Arrakis and Greenjets in the same period: a concentrated bet on physical-world AI and aerospace.
ispace-EUROPE — Luxembourg · €65M ESA contract · Space infrastructure / Lunar rover · European Space Agency
ESA's first-ever commitment to land its own rover on the lunar surface, signed July 24. The MAGPIE rover will search for water ice at the Moon's south pole — the resource that makes sustained human presence economically viable. Institutional rather than venture capital, but it changes the risk profile for sovereign European space infrastructure.
SWISSto12 — Renens, Switzerland · $70M · Series C · Satellite manufacturing · Investors not disclosed
Seven contracted GEO satellites with SES and Viasat, $500M in backlog, $140M in 2025 revenues. The Series C funds manufacturing capacity to meet sovereign and commercial demand. European sovereign space infrastructure is converting government backlog into private capital at a consistent pace.
The pattern: four of five rounds this week involve a government body or industrial corporate already committed as a paying customer — ESA, Schaeffler, Bosch, SES. European deep-tech capital is concentrating around companies where the first customer has voted with a contract, not a letter of intent.
📈Where EU Money Is Flowing
Three Structural Shifts
Physical AI has its European moment. Humanoid at $1.35B, Arrakis at $140M post-money, ispace-EUROPE with its ESA contract — this week's rounds establish physical AI as a distinct European investment category, not an extension of the language model wave. The common attribute is embodiment: AI systems that act in factories, airspace, and orbit. Blossom Capital backed both Arrakis and Greenjets in the same period. Prime Movers Lab led Humanoid. These are not generalist bets — they are thesis funds making concentrated calls on the physical-world AI stack.
Corporate industrials are writing the growth-stage cheque. Schaeffler and Bosch co-invested in Humanoid not through a corporate venture arm but as direct equity holders with manufacturing commitments. This follows RWE in Proxima Fusion and Rheinmetall in Kraken over the past three weeks. The pattern: European industrial balance sheets are being used to secure technology supply chains through minority equity stakes combined with procurement commitments. For founders in robotics and industrial AI, the question is no longer only which VC will lead — it is which corporate will anchor and provide a commercial runway.
The ETCI 2.0 reshapes the growth-stage ceiling. The European Tech Champions Initiative 2.0, unveiled July 14, targets up to €80 billion in mobilised capital from the EIB Group, EU governments, and institutional investors including Banco Santander, BBVA, Danske Bank, and AltamarCAM. Four times the size of the original ETCI, it is designed to close the growth-stage funding gap at which European companies historically went to US capital or relocated. Founders approaching Series B and beyond now have a structured institutional pathway that did not exist 18 months ago.
💡One Move
Reclassify Your AI Before September 2
The EIC Accelerator full proposal deadline is September 2 — 37 days from today. If you have already submitted a short application and received an invitation to a full proposal, the Omnibus changes your compliance section materially. EIC evaluators score regulatory risk explicitly: a company that correctly identifies its AI system as out of scope under the narrowed Annex III definition — or that documents its path to compliance under the new extended timeline — presents materially lower risk than one writing against pre-Omnibus definitions.
The specific step: take the Omnibus narrowing test to your product. Does your AI system merely assist users or optimise performance without creating health or safety risks? If yes, you are likely outside high-risk scope — document that explicitly. If you fall within the raised SME threshold (750 employees, €150M revenue), document your access to simplified compliance frameworks. Either update strengthens your EIC narrative, sharpens investor materials, and removes a discount that European AI startups have been carrying into every meeting for two years. Thirty-seven days is enough time to do this correctly.
Get it every Monday
Free · 5 min read · Unsubscribe anytime
← All 10 issuesEUACC · Get funded. Build Europe.